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Decompression sickness (DCS) develops due to inert gas bubble formation in bodily
tissues and in the circulation, leading to a wide range of potentially serious clinical
manifestations. Its pathophysiology remains incompletely understood. In this study,
we aim to explore changes in the human leukocyte transcriptome in divers with DCS
compared to closely matched unaffected controls after uneventful diving. Cases (n = 7)
were divers developing the typical cutis marmorata rash after diving with a confirmed
clinical diagnosis of DCS. Controls (n = 6) were healthy divers who surfaced from
a ≥25 msw dive without decompression violation or evidence of DCS. Blood was
sampled at two separate time points—within 8 h of dive completion and 40–44 h
later. Transcriptome analysis by RNA-Sequencing followed by bioinformatic analysis
was carried out to identify differentially expressed genes and relate their function to
biological pathways. In DCS cases, we identified enrichment of transcripts involved in
acute inflammation, activation of innate immunity and free radical scavenging pathways,
with specific upregulation of transcripts related to neutrophil function and degranulation.
DCS-induced transcriptomic events were reversed at the second time point following
exposure to hyperbaric oxygen. The observed changes are consistent with findings
from animal models of DCS and highlight a continuum between the responses elicited
by uneventful diving and diving complicated by DCS. This study sheds light on the
inflammatory pathophysiology of DCS and the associated immune response. Such data
may potentially be valuable in the search for novel treatments targeting this disease.
Keywords: decompression sickness, decompression illness, scuba diving, transcriptome, leukocyte gene
expression, myeloid cell, immediate early genes
INTRODUCTION
Decompression sickness (DCS) is a potentially fatal condition usually observed after scuba diving.
It involves bubble formation in blood and tissues from dissolved inert gas (usually nitrogen
or helium), secondary to a decrease in ambient pressure (decompression). Its manifestations
range from a mild illness to a rapidly life-threatening one. One subtype of DCS presents with
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cutaneous manifestations, termed cutis marmorata. Cutis
marmorata manifesting after diving is pathognomonic of DCS.
It consists of a patchy, geographical rash usually crossing
the midline, commonly involving fatty tissues such as the
abdomen, breasts, buttocks, thighs, but also the torso and back.
It is well-established that this subtype of DCS is associated
with arterialization of bubbles via intracardiac right-to-left
shunting of venous gas emboli, most commonly due to the
presence of a patent foramen ovale (PFO) (Wilmshurst,
2015). Another potential mechanism is through right-to-
left shunting via intrapulmonary arteriovenous anastomoses
(IPAVA) (Madden et al., 2015). This subtype of DCS is therefore
distinct from musculoskeletal DCS, which is thought to be
due to the presence of in situ autochthonous bubble formation
(Edmonds et al., 2015).
The standard treatment for DCS involves oxygen delivered
at an elevated ambient pressure, hyperbaric oxygen (HBO).
Following hyperbaric treatment, complete resolution of
symptoms occurs in 80–90% of cases (Edmonds et al., 2015).
Yet, victims may suffer from long-term sequelae. Of note, DCS
involving the spinal cord is challenging to treat. It may result
in permanent paraplegia or paraparesis, together with bladder
dysfunction with or without incontinence and sexual dysfunction
(Tournebise et al., 1995). The search for new treatments for DCS
as adjuncts to HBO and fluid resuscitation has so far been
largely unsuccessful, with only weak evidence encouraging the
use of lidocaine and the non-steroidal anti-inflammatory drug
tenoxicam (Bennett et al., 2012; Edmonds et al., 2015).
Transcriptomic studies provide an opportunity to explore the
pathophysiologic pathways and the underlying transcriptional
mechanisms that drive disease. Potentially, this can serve as a
stepping-stone toward the identification of novel biomarkers
or druggable targets. Gene expression studies in humans have
focused on cohorts of divers completing uneventful free diving
or scuba diving. Eftedal et al. (2013) characterized the peripheral
blood leukocyte transcriptome in healthy, experienced human
scuba divers, and demonstrated upregulation of transcripts
associated with apoptosis, inflammation, and the innate
immune responses. Diving-induced leukocyte-specific shifts in
transcriptional patterns were described, with downregulation of
genes expressed by CD8+ T-lymphocytes and natural killer cells,
and upregulation of genes expressed by neutrophils, monocytes,
and macrophages (Eftedal et al., 2013). Human studies have
demonstrated increased expression of antioxidant enzymes
in healthy uneventful scuba diving, including upregulation of
catalase (CAT), superoxide dismutase 1 (SOD1), and glutathione
synthetase (GSS) (Kiboub et al., 2018; Perović et al., 2018).
Additionally, diving triggers the development of a systemic
proinflammatory state through altered regulation of genes in
immune pathways (Tillmans et al., 2019; Mrakic-Sposta et al.,
2020). Similarly, freediving elicits changes in the leukocyte
transcriptome, with an increase in neutrophil granulocytes and
a decrease of cytotoxic lymphocytes possibly driven by hypoxia
(Eftedal et al., 2016).
Animal models have also demonstrated upregulation of
proinflammatory signaling molecules in DCS (Bigley et al., 2008;
Liu et al., 2014; Wang H.T. et al., 2015). Both uneventful diving
and DCS trigger changes in the peripheral blood transcriptome,
and distinguishing physiological responses from pathological
changes is a major challenge. To the best of our knowledge,
no study has evaluated a DCS-induced transcriptomic signature
in humans. In this study, we aim to explore the evolution
of leukocyte gene expression in human subjects with DCS
compared to closely matched divers after uneventful diving using
a hypothesis-free RNA sequencing approach.
MATERIALS AND METHODS
Ethics Statement
This study was approved by the institutional ethics review board
of the University of Malta (FRECMDS_1718_058). All subjects
gave written informed consent for their participation in the study
and for genetic analysis. The study protocol is in compliance with
the Declaration of Helsinki.
Patient Selection and Inclusion Criteria
Recruitment of DCS cases (n = 7) and controls (n = 6) was carried
out by a diving medicine physician. Details of specific inclusion
and exclusion criteria are presented in Supplementary Table 1.
Briefly, the control group consisted of scuba divers performing
recreational diving with local diving clubs. Diving club members
received an invitation to participate on a voluntary basis. Divers
satisfying the inclusion and exclusion criteria were consented,
recruited, and sampled at Mater Dei Hospital, Malta. DCS cases
were included in this study if they presented with the typical cutis
marmorata rash within 8 h of surfacing from an underwater dive.
Control subjects were divers who surfaced from a deep dive (≥25
msw) without dive table violation and without any symptoms
suggestive of DCS as ascertained by a diving medicine physician.
Specific exclusion criteria included (a) age < 18 years (b) self-
reported consumption of alcohol and/or strenuous physical
activity before T2 (c) symptoms suggestive of delayed DCS
presentation in controls at T2 d) acute life-threatening clinical
complications or death within 72 h of surfacing. The Francis
and Smith classification for dysbaric illness was recorded for
each subject (Francis and Smith, 1991). All study subjects were
unrelated and of Caucasian ethnicity, and none suffered from
diabetes mellitus, hypertension, asthma, ischemic heart disease,
or congestive heart failure at the time of sampling.
Hempleman’s stress index (Q = P
√
t) was computed for each
dive in both groups, where Q = exposure index (ATA.min0.5),
P = maximum depth in atmospheres absolute (ATA), and t = total
dive time in minutes (Hempleman, 1952). This exposure index
has been used to limit commercial diving in previous studies
(Hugon et al., 2018). Additionally, the gas burden as per the
Francis and Smith classification of dysbaric illness was recorded
(Mathieu, 2006). According to this classification, gas burden is
defined as—I. Low (e.g., within prescribed no decompression
limits), II. Medium (e.g., a dive requiring decompression stops
prior to surfacing) and III. High (e.g., violation of prescribed
decompression requirements).
For both DCS cases and controls, whole blood was sampled
at two time points, T1—within 8 h of surfacing from diving
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and T2—at 40–44 h after surfacing. At T1, controls received
instructions to follow with regards to behavior/lifestyle in the
period prior to the second sampling time. This included fasting
for 10 h prior to the second sampling time, avoiding caffeine
and alcohol intake and avoiding strenuous exercise. Identical
instructions were provided to recruited DCS cases to follow
prior to T2. All DCS cases received emergency HBO as per
United States Navy Treatment Table Six between T1 and T2.
Data Collection
For all participants, information on dive profile (maximum
depth, bottom time, total time of dive, gas mix), the number of
dives within the previous 7 days, and previous history of DCS was
recorded. Additionally, age, gender, body mass index, smoking
status, past medical history, drug history, illicit substance use,
caffeine intake on the day of the dive and alcohol during the 24 h
prior to the first dive of the day were also recorded.
Sample Processing and RNA Sequencing
For RNA isolation, 2.5 mL of whole blood was collected in a
PAXgene R© Blood RNA Tube (PreAnalytiX, Qiagen/BD) from
DCS cases and controls at both T1 and T2. The samples
were frozen within 24 h and stored at -80◦C till further use.
RNA was extracted using the PAXgene R© blood kit (PreAnalytiX,
Qiagen/BD) and quantified by 260/280 nm absorbance using
UV-spectrophotometry (Nanodrop R©, Thermo Fisher Scientific).
The quality of RNA was evaluated by RNA Integrity Number
(RIN) determination using the RNA6000 Nano protocol on
an Agilent 2100 Bioanalyzer system (Agilent, United States).
The RIN values for samples undergoing transcriptome analysis
ranged from 7.8 to 9.3. Depletion of alpha and beta globin mRNA
was carried out using the GLOBINclearTM kit (Thermo Fisher
Scientific). To minimize batch effects, all samples were processed
simultaneously by the same investigator.
RNA samples were submitted for library generation and
sequencing by the Beijing Genomics Institute (BGI-Shenzhen).
Briefly, poly(A) mRNA was enriched using poly(T) oligo-
attached magnetic beads, followed by fragmentation. First strand
cDNA synthesis was carried out using random hexamer N6
primers and reverse transcriptase. Following adaptor ligation
to cDNA fragments, PCR amplification and purification, single
stranded DNA circles were generated in a final library. DNA
nanoballs (DNBs) were subsequently generated by rolling circle
replication, which underwent paired end sequencing (100 bp) on
the BGI DNBseq platform.
Data Processing and Bioinformatic
Analysis
Raw reads were filtered using SOAPnuke (BGI-Shenzhen) and
clean reads mapped to the reference human genome (GRCh37)
using HISAT2 (Li et al., 2009; Kim et al., 2019). Transcript
counts were obtained using RSEM (RNA-Seq by Expectation
Maximization) and normalized as FPKM (Fragments Per
Kilobase of transcript per Million mapped reads (Li and Dewey,
2011). The DESeq2 algorithm was used to evaluate differentially
expressed genes (DEGs) (Love et al., 2014). The p-values
were adjusted for multiple comparisons by the Benjamini and
Hochberg method, and differential expression of the genes
was determined using a false discovery rate (FDR) cutoff
of <0.05 (Benjamini and Hochberg, 1995). DESeq2 analysis was
performed on normalized expression data to include only genes
expressed at the level of 1 or higher using default parameters
in iDEP. To select DEGs, a fold change of more than ± 2
(log2FC > 1) was used, in view of the relatively low range of
dispersion of log2FC values detected.
Principal component analysis (PCA) was used to explore
the clustering of data and to characterize the inter-and intra-
group variability. Gene expression heatmaps, k-means clustering
of DEGs and analysis of tissue-specific co-expression patterns
were explored using iDEP.911 and the TopFunn module of the
TopGene Suite software (Division of Biomedical Informatics,
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH)
(Chen et al., 2009; Ge et al., 2018). This analysis relates the
observed DEGs’ patterns to specific tissues and cell types.
To gain insight into the functional attributes of DEGs,
pathway analysis was carried out using iPathwayGuide (Advaita
Bioinformatics, Michigan, United States) and Reactome
(Ahsan and Drăghici, 2017; Jassal et al., 2020). iPathwayGuide
implements an “Impact Analysis” approach that takes into
consideration the direction and type of all signals on a pathway
to identify putative mechanisms that can explain the measured
gene expression changes (Donato et al., 2013). Pathways were
analyzed in the context of data obtained from both Kyoto
Encyclopedia of Genes and Genomes (KEGG) and Reactome
databases, and ontology data was analyzed using the Gene
Ontology Consortium database (Ashburner et al., 2000; Kanehisa
and Goto, 2000). Functional analysis was carried out using
both iPathwayGuide and Reactome in view of discrepancies in
pathway resources between databases that limit interoperability
and might influence results (Domingo-Fernández et al., 2018).
DEGs were also evaluated by comparison to published datasets
describing the acute effects of scuba diving on the peripheral
blood transcriptome (Eftedal et al., 2013). Enrichr was used
to explore transcriptional regulatory networks and to identify
transcription factors (TFs) enriched for target genes using the
gene set library from the ChIP-x Enrichment Analysis (ChEA)
database (Lachmann et al., 2010; Chen et al., 2013).
Summary Sequencing Metrics
For all samples, sequencing generated approximately 6 Gbp of
data, with Q20 scores over 98% and a median mapping ratio of
72% (IQR 1.5). Using DESeq2, we identified 159 DEGs in the
comparison between uneventful diving controls at T1 and DCS
cases at T1 (130 upregulated genes in DCS, 29 downregulated
genes in DCS)—Supplementary Tables 2, 3. For the comparison
of DCS cases at T1 with DCS cases at T2, 300 DEGs were
identified (41 upregulated in DCS cases at T2, 259 downregulated
in DCS cases at T2)—Supplementary Tables 4, 5. No transcripts
exceeded significance thresholds for the comparison between
controls at T1 vs. controls at T2. Pairwise comparison of controls
1http://bioinformatics.sdstate.edu/idep/
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at T2 with DCS cases at T2 identified only three transcripts which
were significantly upregulated in DCS—Supplementary Table 6.
qPCR Validation
Independent validation of RNA sequencing data was sought by
evaluating the direction and magnitude of differential expression
for selected genes using two-step reverse transcription—
quantitative PCR (RT-qPCR). Five genes were randomly selected
from the DEG pool (PTGDR2, G0S2, AREG, IL5RA, and
BMX). Primers were designed using Primer3 and verified for
specificity using NCBI-BLAST (Rozen and Skaletsky, 2000;
Kent, 2002). Two hundred nanograms of RNA per subject was
used for cDNA library synthesis using the GoScriptTM Reverse
Transcription System (Promega Corporation). The first-strand
cDNA synthesis reaction was primed with oligo(dT) primers.
Following reverse transcription, a 1:5 dilution of the cDNA
library was used as a template for a quantitative PCR reaction.
qPCR was carried out in triplicate using an EvaGreen R© Master
mix (Solis BioDyne, Estonia) and a BioRad CFX96 instrument.
The relative expression of each gene was determined using the
2−11CT method. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as housekeeping gene reference standard.
Primer sequences are listed in the Supplementary Material.
Expression patterns of the five selected transcripts matched
the direction of expression observed from the RNA-Seq data
(Supplementary Material).
Statistical Analysis
Analysis of clinical data was performed using IBM SPSS v26.
The Kolmogorov-Smirnov and Shapiro-Wilk tests as well as
visual inspection of Q-Q plots were used to assess the normality
of distribution of quantitative variables. Since most variables
showed a skewed, non-normal distribution, non-parametric
statistics were used. Pairwise comparison between case and
control groups was carried out using the Mann-Whitney U
test for continuous and ordinal dependent variables. Categorical
dependent variables were compared using Fisher’s exact test.
Numerical data is presented as medians (interquartile range) and
categorical data is presented as percentages. A p-value of < 0.05
was considered statistically significant.
RESULTS
Clinical and Dive Characteristics of the
Study Cohort
The baseline clinical characteristics of the seven divers with
clinical DCS and six unaffected controls who met the inclusion
criteria is shown in Table 1, and detailed dive characteristics
in Table 2. No statistically significant differences in baseline
demographics, dive characteristics and the Hempleman stress
index between case and control subjects were present. No
difference in median C-reactive protein (CRP) levels between
cases and controls at T1 was detected (0.7 mg/L vs. 1.3 mg/L,
p = 0.223). Cases at T2 had significantly higher CRP levels than
cases at T1 [5.5 (5.45) mg/L vs. 0.7 (1.5) mg/L, p = 0.015]. In
TABLE 1 | Clinical characteristics of the study group.
Characteristics DCS cases (n = 7) Controls (n = 6) p-value
Age 35 (6) 40 (2) 0.133
Gender:
Males n(%) 5 (71) 4 (67)
Females n (%) 2 (29) 2 (33) 0.999
Body mass index (kg/m2) 26.3 (4.0) 26.5 (1.9) 0.568
Previous DCS:
Yes n (%) 1 (14) 1 (17)




Yes n (%) 1 (14) 2 (33)
No n (%) 6 (86) 4 (67) 0.559
Drug history:
Yes n (%) 1 (14) 3 (50)
No n (%) 6 (86) 3 (50) 0.266
Illicit drug use within the
previous 1 month:
Yes n (%) 2 (29) 0 (0)
No n (%) 5 (71) 6 (100) 0.462
Alcohol within 24 h of
the first dive of the day:
Yes n (%) 6 (86) 3 (50)
No n (%) 1 (14) 3 (50) 0.266
Smoking Status:
Current Smoker (%) 3 (43) 2 (33)
Ex-smoker n (%) 0 (0) 1 (17)
Non-smoker n (%) 4 (57) 3 (50) 0.999
Caffeine intake on the
day of the dive:
Energy drink n (%) 1 (14) 1 (16)
Coffee n (%) 4 (57) 4 (67)
Tea n (%) 0 (0) 0 (0)
Nil n (%) 2 (29) 1 (16) 0.681
Numerical data is presented as medians with interquartile ranges, categorical data
is described as percentages. The interquartile range represents the difference
between the 75th and 25th percentiles. Column values are compared by
Mann-Whitney U test for quantitative variables and by Fisher’s exact test for
categorical variables.
the DCS cases analyzed, the time from surfacing to onset of
symptoms was ≤60 min, with a mean time of 26 min. On first
review by the diving medicine physician at the accident and
emergency department, all seven cases manifested the typical
cutis marmorata rash together with typical history, confirming
the diagnosis of DCS. In six cases, this was the first ever episode
of DCS. Three cases demonstrated multisystem involvement, and
two of these were neurological-type DCS (vestibulocochlear or
cerebral). There was no evidence of spinal cord involvement
in any of the DCS subjects. One subject presented with limb
pain; however, this was not exclusive limb-pain DCS since it
was accompanied by a typical cutis marmorata skin rash and
preceded by dyspnea. Four cases were cutaneous-only type DCS.
Further details according to the Francis and Smith classification
for dysbaric illness are provided in Supplementary Table 9. Of
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TABLE 2 | Detailed dive and sampling time characteristics.
Characteristics Cases (n = 7) Controls (n = 6) p-value
Gas burden:
Low n(%) 3 (43) 3 (50)
Medium n(%) 4 (57) 3 (50)
High n(%) 0 (0) 0 (0) 0.999
Hempleman’s stress index (ATA.min0.5) 29.9 (6.9) 31.6 (3.7) 0.589
Bottom time (mins) 25.0 (15.5) 21.5 (4.5) 0.385
Total dive time (mins) 55.0 (18.5) 59.5 (13.8) 0.830
Maximum depth (msw) 31.0 (3.8) 32.2 (2.4) 0.315
Time between surfacing and sampling
time 1 (h)
2.7 (0.5) 3.8 (1.3) 0.475
Time between surfacing and sampling
time 2 (h)
42.9 (2.5) 43.7 (2.6) 0.775
Quantitative variables are presented as medians with interquartile ranges. The
interquartile range represents the difference between the 75th and 25th percentiles.
Categorical data is presented as percentages. Column values are compared by
Mann-Whitney U test for quantitative variables and by Fisher’s exact test for
categorical variables.
note, three cases required further hyperbaric treatments after
their initial emergency DCS hyperbaric treatment.
DCS Cases and Diving Controls at T1
The molecular signature of the identified DEGs was interrogated
using gene enrichment and pathway perturbation analysis.
In the comparison of DCS cases vs. diving controls at T1,
statistical enrichment of genes driving cell proliferation in
the colorectal cancer and PI3K-AKT signaling pathways was
detected. Additionally, significant enrichment for transcripts
with immune function in malaria, rheumatoid arthritis, C-type
lectin receptor signaling, and Toll-like receptor signaling
pathways was observed (Table 3). The top upregulated transcripts
in this group include AREG (Amphiregulin) and EREG
(Epiregulin), FOS and G0S2. AREG and EREG are secreted
peptide autocrine hormones and members of the epidermal
growth factor (EGF) family of proteins. They are involved in
a wide range of biological processes including inflammation,
wound healing, and cell proliferation (Zaiss et al., 2015). The
FOS gene encodes a leucine zipper protein that dimerizes with
proteins of the JUN family, thus forming transcription factor
complex AP-1. It regulates cell proliferation, differentiation,
and transformation. Expression of the FOS has also been
associated with apoptotic cell death and muscle injury (Preston
et al., 2000). The phosphatidylinositol 3’-kinase (PI3K)-AKT
signaling pathway is activated by many types of cellular
stimuli or toxic insults and regulates fundamental cellular
functions such as transcription, translation, proliferation, growth,
and survival. AKT functions in the control of key cellular
processes by phosphorylating substrates involved in apoptosis,
protein synthesis, metabolism, and cell cycle. Additionally,
early response genes were observed to be upregulated in
this comparison.
Gene ontology (GO) category enrichment analysis showed
statistical overrepresentation of transcripts involved in
chemotaxis, cell surface receptor signaling and cytokine
production (GO—Biological processes). PCA revealed a
difference in transcriptome profile between DCS cases and
controls at T1, with the first two principal components
explaining 63% of the variability across the two biological
groups. A greater heterogeneity in transcriptomic profiles
amongst replicates in the DCS group was observed, which
can potentially be attributed to clinical heterogeneity.
No significant overlap in datapoints representing cases
and controls occurs, indicating relative uniformity in
gene expression signatures within cases and control
groups (Figure 1).
Comparison DCS Cases at T1 and T2
The comparison of gene expression signatures between
DCS cases at T1 and T2 revealed significant differences
in several transcripts (Figure 2). Pathway analysis of the
DEGs exceeding significance thresholds for the casesT1-
casesT2 comparison revealed statistical enrichment of the
neutrophil degranulation, signaling by interleukins, IL-10
signaling, IL-4 and IL-13 signaling, and immune system
pathways (Table 4). Importantly, almost all transcripts
in these pathways were observed to undergo significant
downregulation at T2. Gene ontology category analysis revealed
overrepresentation of transcripts involved in neutrophil
activation and degranulation (GO-biological process), RAGE
receptor binding (GO-molecular function), and secretory
granules (GO-cellular components).
TABLE 3 | The top overrepresented pathways identified through impact analysis of DEGs in the casesT1-controlsT1 comparison.
Pathway Pathway ID No. of genes
(DE/All)
p-value Overrepresented genes on pathway
Colorectal cancer KEGG–05210 3/85 2.593 e-4 AREG, EREG, FOS
PI3K-AKT signaling KEGG–04151 Reactome–
R-HSA-2219530
8/314 2.617 e-4 AREG, THBS1, EREG, KITLG, ANGPT1,
SGK2, TLR4, GNG2
Malaria KEGG–05144 4/48 0.002 THBS1, CXCL8, SDC2, TLR4
Rheumatoid arthritis KEGG–05323 5/85 0.003 CXCL8, ANGPT1, CCL3, TLR4, FOS
C-type lectin receptor signaling KEGG–0425 4/103 0.003 EGR3, CLEC4D, CLEC4E, CLEC6A
Toll-like receptor signaling KEGG–04620 5/93 0.006 CXCL8, CCL4, CCL3, TLR4, FOS
Cytokine signaling in the immune system Reactome–R-HSA-
1280215
9/676 0.0155 FOS, IRS2, IL1R2, MAPK8, LGALS9,
BCL2, SERPINB2, CCL4
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FIGURE 1 | (A) Volcano plot showing the top 10 significant differentially expressed genes (DEGs between controls and DCS cases at T1. The volcano plots
distribution of log fold change (x-axis) and the negative log (base 10) of the p-values (y-axis). Upregulated genes are shown in of red while downregulated genes are
shown in blue. (B) Heatmap of DEGs for the comparison of controls and cases at T1. Genes on heatmap are organized by hierarchical clustering based on the
overall similarity in expression patterns. (C) Bar plots showing the top five enriched Gene Ontology terms. (D) Principal component analysis (PCA) depicting sample
relationship based on dynamic gene expression. PCA identified two clusters in the data separated along the first and second principal components. The
percentages on each axis represent the percentages of variation explained by the principal components. PC1 and PC2 define 49 and 14% of the variance,
respectively. The distance between the points reflects the variance in gene expression between them. No significant overlap in datapoints representing cases and
controls occurred, indicating relative uniformity in gene expression signatures between cases and controls.
To better characterize the time course of events following the
initial DCS event, we evaluated similarities and differences with
the DEGs arising from the case-control at T1 analysis. Ninety-
six genes were exclusive to the comparison between casesT1-
controlsT1, 237 genes were exclusive to the comparison between
casesT1 and casesT2, and 63 genes were in common to both
datasets, i.e., they were identified to be differentially expressed in
both comparisons (Figure 2). Mechanistically, it is plausible to
propose that the 96 genes which were exclusive to the casesT1-
controlsT1 comparison represent the early phase of the response
to DCS. Furthermore, the 237 genes which were exclusive to the
casesT1-casesT2 comparison represent a combination of (a) the
later (delayed) manifestations of DCS, (b) the pathophysiological
response to DCS involving repair and recovery mechanisms,
and/or (c) the physiological response to HBO. All DCS cases
recruited in this study made complete clinical recovery by T2,
hence it is unlikely that the 237 transcripts unique to the casesT1-
casesT2 comparison reflect an ongoing or sustained response to
DCS. Nevertheless, a prolonged subclinical pathophysiological
reaction cannot be excluded.
To further relate the transcriptomic signature to the clinical
resolution of DCS and the effects of HBO, we evaluated
the direction of gene expression change in the DEG list
at the intersection of the two datasets. These 63 transcripts
exceeded statistical thresholds of significance in both the
casesT1-controlsT1 and casesT1-casesT2 comparison, suggesting
that their expression is causally related to the development
and/or progression of DCS. Interestingly, for all the 63
genes, the direction of expression was completely reversed
in cases at time point 2 compared to cases at time point
1, indicating that the resolution of DCS and the exposure
to HBO significantly impacts on their expression. Pathway
enrichment analysis applied to the 63 DEGs at the intersection
of the two comparison reveals statistical overrepresentation
of PI3K signaling (p = 4.8 × 10−3), consistent with earlier
results demonstrating significant perturbation of the PI3K-AKT
pathway in DCS cases compared to controls.
Exploratory PCA analysis was also applied to gene expression
data from the four biological groups (DCS cases at T1 and
T2, uneventful diving controls at T1 and T2 considered in
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FIGURE 2 | (A) Volcano plot showing the top 10 significant DEGs between DCS cases at T1 and DCS at T2. Upregulated genes are shown in red while
downregulated genes are shown in blue. (B) Heatmap of differentially expressed genes (DEGs) for the comparison of DCS cases at T1 vs. DCS cases at T2. Genes
on heatmaps are organized by hierarchical clustering based on the overall similarity in expression patterns. The volcano plots distribution of log fold change (x-axis)
and the negative log (base 10) of the p-values (y-axis). (C) Venn diagram illustrating DEG overlap between the caseT1-controlT1 and caseT2-controlT2 comparison.
63 transcripts at the intersection showed significance in differential expression across both comparisons. The heat map shows that the direction of expression of
these transcripts is reversed at T2, suggesting that the resolution of DCS or the exposure to hyperbaric oxygen impacts on their expression. (D) Bar plots showing
the top 5 enriched Gene Ontology terms for the caseT2-caseT1 comparison.
TABLE 4 | The top overrepresented pathways identified through impact analysis of DEGs in the casesT1-casesT2 comparison.
Pathway Pathway ID No. of genes
(DE/All)
p-value Overrepresented genes on pathway
Neutrophil degranulation R-HSA-6798695 43/480 4.44 e-16 CDA, ORM1, TNFAIP6, HP, SLC2A3, CXCL1, GPR84
Signaling by interleukins R-HSA-449147 33/639 9.88 e-7 CXCL8, CEBPD, IL1R1, IL1R2, IL34, ALOX15, OSM, IL5RA, CXCL1, IRS2,
FOS
Il-4 and Il-13 signaling R-HSA-6785807 16/211 8.33 e-6 SOCS3, IL1A, CXCL8, CEBPD, BCL6, ALOX15, OSM, FOS, PTGS2,
MMP9
Immune system R-HSA-168256 87/2,869 3.23 e-5 CDA, ORM1, CXCL8, TNFAIP6, HP, IL5RA, SLC2A3, CXCL1, IRS2, PYGL
Il-10 signaling R-HSA-6783783 9/86 7.75 e-5 IL1A, CXCL8, IL1R1, IL1R2, CXCL1, FPR2, PTGS2
TNF signaling KEGG–4668 7/110 0.0006 MMP9, SOCS3, FOS, PTGS2, CXCL1, CREB6, IL18R1
aggregate). PCA shows absence of separation between DCS
cases at T2 and uneventful diving controls, while DCS cases
at T1 demonstrated within-group heterogeneity and clustered
differently from controls. Two distinct but broad clusters can
be detected, largely defined by DCS cases at T1 and most of
the controls (Figure 3). This analysis demonstrates that divers
after uneventful diving demonstrate a relatively distinct gene
expression signature from DCS cases. A greater heterogeneity in
transcriptomic response can be observed in divers with DCS at
times 1 and 2. It is plausible to propose that this heterogeneity
in part reflects the combined effects of clinical treatment and
varying resolution of the inflammatory stimulus.




K-means clustering was used to group gene expression signatures
and to explore the GO terms enriched for each cluster. This
unsupervised method enables the identification of transcripts
that are co-functional and are coregulated. Based on the within-
group sum of squares, k = 4 was chosen. The top 1,000 variable
genes were included the analysis. K-means cluster analysis
shows that genes in cluster A, strongly enriched for myeloid
Frontiers in Physiology | www.frontiersin.org 7 June 2021 | Volume 12 | Article 660402
fphys-12-660402 June 6, 2021 Time: 10:47 # 8
Magri et al. Decompression Sickness: Effects on the Human Transcriptome
FIGURE 3 | (A) PCA analysis of gene expression across sequenced libraries repeated for DCS cases at T1 and T2 and uneventful diving controls at T1 and T2. PC1
and PC2 define 40 and 12% of the observed variance. A third component, PC3, defines 8% of the variance (not shown). Importantly, two distinct but broad clusters
can be detected, largely defined by DCS cases at T1 and most of the controls in aggregate. (B) Heat map showing the top 200 DEGs across the four biological
groups in this study. Genes on heatmap are organized by hierarchical clustering based on the overall similarity in expression patterns. Upregulated genes are shown
in shades of red while downregulated genes are shown in shades of blue.
activation, neutrophil activation and leukocyte degranulation
are upregulated in DCS cases at T1, while genes in cluster B,
enriched for immune system processes, cell surface receptor
signaling and lymphocyte activation were upregulated at T2
in DCS cases. Genes in clusters A and B showed opposing
pattern of expression between DCS cases at T1 and T2, with
expression patterns at T2 in DCS cases being largely similar to
that observed in controls (Figure 4). To further relate the shift
in gene expression patterns with specific leukocyte subtypes, we
performed an analysis of tissue-specific patterns using ToppFun.
The upregulated gene set in DCS cases at T1 are characteristic
of myeloid cells, specifically CD11b + Ly6-G + neutrophils,
monocytes, macrophages, and some dendritic cell subtypes
(19/409 genes in annotation, p = 2.029 × 10−12). These cells
produce Type I interferons and large quantities of reactive oxygen
species (ROS). In keeping with K-means clustering analysis, the
downregulated genes in DCS cases at T2 are again characteristic
of myeloid cells.
Transcriptional Regulatory Networks
Transcriptional regulatory networks were explored using
enrichment analysis of TF target gene sets. For the case T1-
control T1 comparison, target genes of SP1 (FDR = 5.9 × 10−2),
GLIS2 (FDR = 1.1 × 10−2) and PAX5 (FDR = 1.5 × 10−1) were
overrepresented in down-regulated genes, while upregulated
genes are enriched with target genes of HLF (FDR = 8.6 × 10−2)
and FOXK1 (FDR = 1.3 × 10−1). For the case T2-caseT1
comparison, target genes of CEBPB (FDR = 4.82 × 10−4) and
SCL (FDR = 1.73 × 10−3) were overrepresented in upregulated
genes, while downregulated genes were enriched for targets of
BACH1 (FDR = 2.984× 10−7) and ZNF217 (FDR = 3.2× 10−5).
SP1, GLIS2, SCL, and FOXK1 play pivotal roles in cycle
regulation. PAX5 is a known regulator of B-cell development and
CEBPB regulates the expression of genes involved in acute phase
immune and inflammatory responses (Cobaleda et al., 2007, p. 5;
Wang W. et al., 2015).
DISCUSSION
This study describes changes in the peripheral blood leukocyte
transcriptome in divers with cutaneous DCS compared to
matched controls after uneventful diving. It also evaluates the
progression of these transcriptomic changes by comparison
of gene expression at two discrete timepoints. We show that
cutaneous DCS elicits the differential expression of several
transcripts involved in leukocyte activity, inflammation, and
cytokine production, with prominent perturbation of genes
in the PI3K-AKT and TLR pathways. In fresh DCS cases
within 8 h of surfacing from diving, upregulated transcripts
are characteristic of the leukocyte myeloid lineage—specifically
granulocytes. These show a significant downregulation when
evaluated just under 48 h later. The reversal in the direction of
expression of these transcripts is likely attributed to the effects
of HBO and the clinical resolution of DCS. To the best of our
knowledge, this is the first study that evaluates DCS-induced
transcriptomic alterations in man.
DCS Triggers Activation of PI3K-Akt, TLR
Pathways, and Immediate Early Genes
The findings from this study require meaningful interpretation
in the context of existing knowledge on DCS. DCS is a systemic
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FIGURE 4 | K-means clustering analysis applied to the top 1,000 variable genes identifies co-regulated and co-functional transcripts. Genes in cluster A, strongly
enriched for neutrophil activation, degranulation and myeloid activation are variably upregulated in DCS cases at T1. Genes in cluster B, strongly enriched for
lymphocyte activation and T—cell activation are downregulated in DCS cases at T1. As GO terms are related or highly redundant, for each cluster the most
significant terms are presented. Upregulated genes are shown in shades of red while downregulated genes are shown in shades of blue.
pathological process arising from the formation of inert gas
bubbles in supersaturated tissues or blood following decreases in
ambient pressure (Vann et al., 2011). Damage and dysfunction
of the vascular endothelium following decompression has been
reported in a number of animal studies (Nossum et al.,
1999, 2002). Decompression-induced endothelial dysfunction
correlates with bubble formation in rat models of DCS, an
effect which is potentially attenuated by immunomodulatory
drugs such as simvastatin or by NO donors (Møllerløkken et al.,
2006; Zhang et al., 2015, 2016). In our study, acute phase DCS
was accompanied by upregulation of genes involved in acute
inflammation (AREG, EREG, CXCL8, CCL4, EGR3, CLEC4E,
CLEC6A) and innate immunity (TLR4, EGR3). Amphiregulin
(AREG) and epiregulin (EREG) are type II cytokines linked to
a wide variety of inflammatory conditions, such as rheumatoid
arthritis, chronic airway disease and glomerulonephritis (Yamane
et al., 2008; Melderis et al., 2020). AREG skews monocytes
and macrophages into a proinflammatory M1 phenotype, and
the expression of EREG is induced by intermittent hypoxia
(Kyotani et al., 2018). Toll-like receptors function in activation
of the innate immune system, and CXCL8 was the most
strongly upregulated DEG for this pathway. CXCL8 (IL-8) is
a powerful chemoattractant involved in neutrophil recruitment
and chemotaxis. CXCL8 and other chemokines are consistently
among the first signals to be expressed and released by the various
cell types involved in inflammation (de Oliveira et al., 2013;
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Torraca et al., 2017). Animal studies have demonstrated that
acute DCS is accompanied by elevation of proinflammatory
cytokines (TNF-α, IL-6, and IL-1) in both lung tissue and
the circulation (Bigley et al., 2008; Chen et al., 2011). Thus,
the proinflammatory gene expression signature of acute DCS
described here is in keeping with evidence from previous
in vivo animal studies. The acute-phase gene expression signature
described in this report is significantly enriched for neutrophil
and monocyte/macrophage-specific genes. Critically, this pattern
is reversed at 40–44 h after surfacing from diving, following
exposure to HBO. The role of neutrophil activation and
vascular damage following microparticle release has been well-
documented, with studies showing that exposure to inert gases at
high pressure generates oxidative stress (Thom et al., 2011, 2014,
2015). Furthermore, uneventful diving triggers a similar shift
in transcriptional pattern, with upregulation of genes expressed
by myeloid cells and down regulation of CD8+ lymphocyte-
expressed genes (Eftedal et al., 2013). Importantly, Eftedal
et al. (2013) did not assess DCS or HBO exposures. The gene
expression patterns described here are capturing the combined
effect of three interrelated physiological stressors—diving, DCS
and HBO exposure. At the two timepoints analyzed, these
factors exert a varying effect on the magnitude and direction
of the observed gene expression changes. It is likely that
the diving-induced transcriptomic changes in the pathways
observed by Eftedal et al. (2013) may have been obscured
or possibly reversed in this study cohort. Furthermore, it is
plausible to postulate that a direct continuum exists between
the changes induced by uneventful diving and development of
DCS, with the latter developing if the adverse physiological
stimulus is in any way prolonged or sustained. Uneventful diving
triggers a subclinical inflammatory response that can possibly
progress to clinically overt DCS in susceptible individuals under
extreme physiological conditions. In such a scenario, it is
possible to hypothesize that the recruitment and activation of
additional inflammatory pathways would potentially account for
the observed clinical picture of DCS.
Pathway analysis in acute DCS demonstrates significant
overrepresentation of PI3K-AKT and Toll-like receptor
(TLR) signaling. The PI3K-AKT pathway has diverse
cellular roles as it regulates proliferation, metabolism,
survival, migration and tumor initiation (Cantley, 2002;
Manning and Cantley, 2007). AKT positively regulates the
production of reactive oxygen/nitrogen species (ROS/RNS)
by modulating mitochondrial bioenergetics and activation
of NADPH oxidases (Koundouros and Poulogiannis, 2018).
TLR2 and TLR4 recognize pathogen-associated molecular
patterns (PAMPs) on bacterial cell walls and activate innate
immunity through NF-κB activity. TLR signaling augments
activity of the PI3K-AKT pathway, and TLR2 or TLR4
activation on myeloid cells promotes the production of
pro and anti-inflammatory cytokines (Weichhart et al.,
2015). Recently, HBO therapy was shown to reverse AKT
activity in a rat model of neuropathic pain (Liu et al., 2019).
Importantly, Chen et al. (2011) showed that exposure to
compression-decompression activates AKT signal transduction
in the rat lung.
In addition, several other DEGs identified from the
comparison of cases and controls within 8 h of surfacing
from a dive are physiologically important. Of note, EGR3 (Early
Growth Response 3) was upregulated in DCS cases at T1. This
transcription factor induces TGF-β, is a negative regulator
of T-cell activation and is necessary for humoral immune
tolerance (Morita et al., 2016). JCAD (Junctional Cadherin 5
Associated) is a junctional protein linked to proinflammatory
changes and dysfunction of vascular endothelium (Shigeoka
et al., 2020). THBS1 (Thrombospondin 1) is a glycoprotein
secreted by endothelium, where it participates in a broad
array of functions related to vascular inflammation and
cell-cell interactions (Liu Z. et al., 2015). NR4A2 (Nuclear
Receptor Subfamily 4 Group A Member 2) encodes an orphan
nuclear receptor belonging to the steroid-thyroid hormone-
retinoid receptor superfamily. NR4A2 has also been shown
to mediate acute inflammatory cascades (Doi et al., 2008).
Members of the NR4A family are classified as “immediate early
genes” (IEGs) induced by physiological and physical stimuli
(Maxwell and Muscat, 2006). IEGs constitute a gateway to
genomic responses, being rapidly and transiently activated
in response to multiple stimuli. Their induction underlies
acute inflammation (Wu et al., 2019). Gene expression studies
following simulated diving in rats exposed to high bubble loads
showed upregulation of NR4A3, a paralog of NR4A2 (Eftedal
et al., 2012). G0S2 (G0/G1 switch gene 2) was significantly
upregulated in DCS cases at T1. G0S2 has disparate roles and is
implicated in hypoxia-induced positive regulation of oxidative
phosphorylation and induction of apoptosis by interaction with
BCL2. G0S2 is also an early response gene that is upregulated
in autoimmune and inflammatory processes, and functions
in the maintenance of T-cell quiescence (Yamada et al., 2011;
Lee et al., 2015).
DCS Induces Activation of Antioxidant
Defense Mechanisms
Our investigation also showed a significant upregulation of
GPX3 (Glutathione Peroxidase 3) in DCS cases at T1. This
is an extracellular selenocysteine protein that plays a critical
role in the scavenging of ROS. The upregulation of anti-
oxidant pathways including SOD2 and GPX4 in diving has
been described (Eftedal et al., 2013). In our study, SOD2 was
strongly expressed in both DCS cases and controls at T1, with
a higher expression in DCS cases that, however, did not reach
significance thresholds after adjustment for multiple testing. It is
reasonable to postulate that SOD2 was upregulated in response to
diving in both DCS cases and controls, in keeping with previous
studies. SOD2 expression did not differ between controls at
T1 and controls at T2. This is consistent with the findings of
Perović et al. (2018) where the expression of SOD2 normalized
within 6 h post dive. In the casesT1-casesT2 comparison,
nominal but significant downregulation of SOD2 was observed
at T2. Critically, extracellular superoxide activates neutrophils
in a TLR4 dependent manner, and sub-lethal oxidative stress
leads to selective activation of monocytes/macrophages through
scavenger receptors (Lorne et al., 2008; Geiger-Maor et al., 2012).
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Effect of HBO on the Peripheral Blood
Transcriptome
The leukocyte gene expression patterns reported here are
biologically meaningful. In acute DCS, the activation of
inflammatory pathways playing critical roles in body defense
is likely reflecting a physiological reaction triggered by a
powerful exogenous stressor. However, the effect of HBO on
gene expression is controversial and not fully ascertained. The
transcriptomic changes in DCS cases at T2 are driven by the
combined effects of clinical resolution of DCS and HBO therapy.
This study was not designed to examine the relative contribution
of each factor, and to the best of our knowledge the impact
of HBO on the leukocyte transcriptome in man has not been
reported. Limited inferences can be drawn from the literature.
Godman et al. (2010) reported that hyperbaric exposure triggers
the upregulation of antioxidant, cytoprotective, and IEGs in
human microvascular endothelial cells, rendering them resistant
to increased oxidative stress. Woo et al. (2020) showed that HBO
alleviates exercise-induced inflammatory responses and muscle
damage. Other investigators showed that a single HBO treatment
significantly alters the expression of different inflammation and
wound healing genes in endothelial cells at different timepoints
(Kendall et al., 2012). HBO therapy is considered a useful
anti-inflammatory adjunct in various pathologies (Novak et al.,
2016; Hao et al., 2020). Conversely, HBO did not induce any
pro-inflammatory, anti-inflammatory, or antioxidant effects in
surgically induced inflammation in dogs (Gautier et al., 2019).
Recently, a microarray transcriptome study showed that HBO
does not exert significant effects on gene expression during
surgical wound healing in rabbits (Tlapák et al., 2020). Critically,
direct comparison of these studies is limited by differences in
exposure, species, and the analytic methodology applied.
The DCS Transcriptome—Caveats and
Challenges
The interpretation of transcriptomic signatures in DCS
is challenging. Primarily, the DCS phenotype is clinically
heterogenous, an effect which might account for within-group
dispersion of gene expression. Additionally inter-subject and
intra-subject variation in peripheral blood is well-recognized
due to the dynamic nature of this tissue. In attempt to increase
homogeneity in the DCS case cohort, we selected to only include
divers exhibiting the cutis marmorata rash. This cutaneous
manifestation is indicative of a systemic DCS pathology and an
inflammatory response to nitrogen bubbles (Kalentzos, 2010).
Cutis marmorata is not a universal feature of DCS and it is
possible that the findings reported here are skewed toward one
clinical subtype of DCS, and thus may not be generalizable to
all forms of DCS. Secondly, acclimation to decompression has
been described in rodent models (Montcalm-Smith et al., 2007,
2009). Chen et al. (2011) further show that repeated exposure
to compression-decompression stress induces changes in EGR-1
and cytokine expression, although no acclimation-specific
changes were detected. The physiological and molecular basis
of acclimation are unknown, although reduced bubble load and
attenuation of host responses have been suggested to play a role
(Huang et al., 2003; Pontier et al., 2009). It is likely that the
transcriptomic changes reported here are confounded to varying
extents by interindividual differences in acclimation responses.
Are the Observed Transcriptomic
Changes Confounded by Diving?
In view of the low incidence of DCS, this investigation was
not designed to include pre-dive samples from DCS cases and
controls. Pre-dive transcriptomic changes could thus not be
directly investigated or considered as potential confounders.
Furthermore, it is established that uneventful scuba diving
triggers several acute gene-expression changes in blood sampled
within 1 h of diving. Eftedal et al. (2013) characterized DEGs
involved in apoptosis, immune responses, and inflammatory
pathways that can be persistently deregulated in experienced
divers. To increase the robustness and significance of this study,
we sought to evaluate the DEG profile from the casesT1-
controlsT1 comparison in this study to the dataset from
Eftedal et al. (2013) showing acute blood transcriptomic changes
after uneventful scuba diving. This analysis identified only
seven DEGs at the intersection between the two datasets, of
which five were consistently overexpressed in both datasets.
This suggests that their expression is potentially modulated
by the diving process itself rather than DCS. Conversely, two
genes—GZMB and ZFYVE16 showed an opposite direction of
expression when the two datasets were compared. Interestingly,
the magnitude of expression change was higher in DCS cases than
in the Eftedal dataset. Eftedal et al. (2013) identified significant
enrichment for the pathway containing GZMB (granzyme B) in
response to uneventful diving, with GZMB and related genes
undergoing transient change in expression and returning to
predive levels between successive dives. In our dataset, GZMB
underwent significant upregulation in DCS cases compared
to diving controls. GZMB did not, however, exceed statistical
significance thresholds when DCS cases at T2 were included
in the comparison, implicating that upregulation of this gene
may have persisted past 40–44 h from surfacing from the dive
resulting in DCS. Although it cannot be fully evaluated in
this study, its sustained upregulation provides evidence for a
prolonged or persistent pro-inflammatory response. Similarly,
ZFYVE16 overlapped between the two datasets but showed an
opposite direction of expression. The relevance of this locus to
DCS biology is unknown. Comparison with the Eftedal dataset
provides support for a minimal, yet relevant overlap between
physiological responses elicited by uneventful diving and that of
DCS. Furthermore, the absence of transcripts exceeding statistical
significance thresholds between controls at T1 and controls at
T2 reinforces the transient nature of transcriptomic changes,
consistent with previous observations (Eftedal et al., 2013). We
conclude that at the two sampling timepoints in this study,
any gene expression changes induced by uneventful diving
were reversed at T2.
Strengths and Limitations
Our investigation is strengthened by several factors. A unique
human genomic signature of DCS has not been reported
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previously. Here, a biologically agnostic high-throughput RNA
sequencing approach is used. This method carries several
advantages over microarray-based analysis, including low
background noise and a large dynamic range (Hrdlickova et al.,
2017). The RNA sequencing data was further validated using RT-
qPCR. The selection of subjects followed stringent inclusion and
exclusion criteria. To control for gene expression changes that
arise due to diving, a comparably matched cohort of divers after
uneventful diving was recruited. To ensure that the observed
transcriptomic changes are a faithful representation of the DCS
state, care was taken to minimize interindividual differences
amongst the divers selected for this study. The peripheral blood
transcriptome is known to broadly reflect the combined effects of
pharmacotherapy, chronic disease, and environmental exposures
such as smoking (Lampe et al., 2004; Liu Y. et al., 2015; Beretta
et al., 2020; Ustinova et al., 2020). While these factors are integral
components of many human studies, they can cause confounding
in gene expression experiments.
This investigation carries a number of limitations. Primarily,
the study was not designed to include pre-dive samples, hence
the baseline stationary transcriptome could not be compared to
the DCS changes at T1 and T2. DCS has a low incidence and
is inherently unpredictable in nature, thus limiting prospective
follow-up studies (Dardeau et al., 2012). Further investigations
using simulated diving in animal models are necessary to clearly
elucidate the transcriptomic effects of DCS and their time course.
The small number of DCS cases meeting inclusion criteria
necessitated the use of convenience sampling as opposed to
random sampling, and selection bias cannot be fully excluded.
In human subjects, the accurate quantification of decompression
stress in uncontrolled environments is difficult. Despite our best
efforts to ensure phenotypic homogeneity and comparability
of the case and control cohorts, it is likely that uncontrolled
factors persist. These may include differences in dive profiles and
breathing gas composition that could modulate gene expression.
The three-tier Francis and Smith classification and Hempleman’s
stress index may not fully capture the dynamic variation in dive
characteristics or decompression profiles that could impact on
the eventual clinical course. Additionally, we acknowledge that
the unavailability of dive computer profile data and information
on recent earlier diving is a significant limitation. Furthermore,
gene expression data was not correlated to the quantitative
determination of serum cytokine levels. A poor correlation
between RNA expression and protein levels has been reported, in
part due to variations in translational efficiency (Schwanhäusser
et al., 2011; Cenik et al., 2015). Future research should also strive
to evaluate the immunophenotype of peripheral blood leukocytes
in response to DCS using flow cytometry to better define the
inflammatory landscape in DCS.
Peripheral blood leukocytes were the primary source of RNA.
These cells represent a highly heterogenous cell population,
and dilution of biological effects due to the heterogenous cell
population possibly accounts for the low range of log2FC
(log2FC < 3) values detected in this study. In the targeted
gene expression diving study by Chen et al. (2011) identically
mild changes in cytokine gene expression were detected in rat
lung. Of note, blood transcriptomic studies often apply arbitrary
ranges of FC cut-offs (Greiner et al., 2013; Gaye et al., 2017;
Dorsey et al., 2019; Ramsay et al., 2019). Furthermore, in many
conditions, the magnitude of expression change in the global
blood transcriptome may be subtle and generally lower than that
observed in tissue-based experiments.
We also acknowledge that this investigation is limited by
its small scale. While the findings from this pilot dataset offer
insight into the transcriptomic responses to DCS, replication
and independent validation in larger cohorts is warranted to
enable robust and unbiased interpretation. Replication studies
should also consider sampling at alternate time points to better
elucidate the dynamics of the stress response elicited by DCS and
its resolution. RNA-sequencing is, however, a powerful, precise
tool in differential gene expression analysis and data robustness
is dependent on the quality of each sample. This study is
strengthened by the use of RNA exceeding the quality thresholds
acceptable for a high throughput sequencing experiment. Quality
control procedures following RNA extraction and bioinformatic
analysis of sequencing data did not flag any outlier sample with
poor quality issues.
Lastly, the paucity of human studies evaluating the DCS
transcriptome limits comparison and interpretation of our
findings. While comparison to various animal studies has been
drawn, it must be emphasized that notable differences exist
between rodents and man in the context of the genomic responses
to acute inflammation (Osterburg et al., 2013; Seok et al.,
2013). Metabolic differences between murine and human M1
macrophages have been described (Vijayan et al., 2019; Palmieri
et al., 2020). Thom et al. (2014) showed that human and murine
neutrophils exhibited similar responses to high pressure gases,
however, murine cell microparticle production persisted even
after decompression.
CONCLUSION
In this report we characterize the transcriptomic response elicited
by DCS and its sequential progression in response to HBO
therapy. This is a pilot investigation that provides a unique
insight into the molecular etiology of this complex condition.
DCS is accompanied by the dynamic regulation of several
inflammatory and innate immune pathways, with a pronounced
shift in transcriptional patterns characteristic of the myeloid
lineage. Activation of free radical scavenging mechanisms is
prominent in DCS. Our findings reinforce the role of acute
inflammation in DCS and provide evidence for a continuum
between the physiological response elicited by uneventful diving
and diving complicated by DCS. Future studies with DCS
cohorts are required to investigate the immunophenotype of
peripheral blood leukocytes, as well as to enquire the epigenetic,
metabolomics, and proteomic landscape of this disease.
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